Hilton Head Island, SC., Sep. 1, 2015 /MJbizwire/ —
After three months of extensive laboratory testing and scientific research by many notable sources, David Mouser, CEO, announced the company has discovered and developed a forth extraction process performed on CBD Pur US Isolate bringing the product to PHARMA GRADE purity. Patents have been initiated to protect the intellectual property pertaining to the 4th critical extraction now used by CBD Pur US. All unwanted plant wax and potentially toxic humic acid have been removed in the process.
CBD Isolate, paste, and oil products all contain humic acid and plant cuticle wax. Humic acid is a natural fertilizer sold for gardening. Consequently, all CBD hemp extractions are subject to growing things. Contamination long range becomes a serious issue regarding “shelf life”. CBD Pur US Isolate PHARMA GRADE now guarantees the industry an unequaled purity for CBD product manufacturers by eliminating these potentially harmful product liability issues (see ProjectCBD, Oct. Page 17-18).
“Responsible companies now have an alternative to avoid potential liability, costly litigation, and loss of market reputation…”
David Mouser, CEO stated, “Responsible companies now have an alternative to avoid potential liability, costly litigation, and loss of market reputation regarding the inherent humic acid issues. CBD Pur PHARMA GRADE is a breakthrough for the CBD industry worldwide. We have now applied the identical 4th extraction process to our new SDP Water Soluable Isolate as well. Oregon Analytical Services confirmed the 99.9% PHARMA GRADE in accordance with ColumbiaBiological.org certification of CBD Pur US. CBD Pur US Isolate is not a synthetic.”
CBD Pur US is the first CBD manufacturer of PHARMA GRADE CBD Isolate distributing worldwide. “We have set an industry standard for all CBD isolate manufacturers, seriously undertaking a leadership role with a passion to maintain accountability to the CBD market space. Look for the CBD Pur US logo on all CBD products. It is your guarantee of PHARMA GRADE CBD. It just makes good sense,” Mouser said.
CBD Pur US main office is in Hilton Head Island, South Carolina with satellite offices in the United Kingdom and Jamaica for export to European, Caribbean, and Latin American manufacturers.
For more information, contact Mr. John Hamilton, Director of Marketing, 843-422-1200 or visit www.cbdpurus.com.